Emeryville, California - September 4, 2001 - HealthCentral (Nasdaq: HCEN), a leading provider of healthcare e-commerce and content, received a letter from Counsel for Nasdaq Listing Qualifications Hearings, which stated that, as of the close of business on August 24, 2001, the Company was not in compliance with two criteria for continued listing on the Nasdaq National Market System. Specifically, the Company had failed to evidence a market value of public float of at least $5 million (as required under Nasdaq Marketplace Rule 4450(a)(2)) for forty-one consecutive trading days, and the Company is not currently in compliance with the net tangible assets/stockholders` equity requirement, as required under Rule 4450(a)(3) (or the alternative listing criteria under Rule 4450(b)(1)). The letter stated that the Company was invited to make a written submission for the Panel`s review and that the Panel would make its determination with respect to the Company`s continued listing on the Nasdaq National Market upon the earlier of receipt of the Company`s submission or the close of business on Tuesday, September 4, 2001.
On September 4, 2001, the Company made its written submission to Nasdaq. The Company noted that it met the public float and stockholders` equity maintenance requirements for listing on the Nasdaq SmallCap Market, and requested that, if the Panel concluded that its stock no longer qualified for trading on the Nasdaq National Market, that the Panel authorize the listing of the Common Stock on the Nasdaq SmallCap Market. The company believes that its request will be granted and that the stock will be granted listing on the Nasdaq SmallCap Market.
About HealthCentral
HealthCentral (Nasdaq: HCEN) is a leading provider of healthcare e-commerce to consumers through WebRxSM, a network of sites representing the consolidation of Vitamins.com, HealthCentral.com, RxList.com and others. Its e-commerce site, WebRxSM (www.webrx.com), features more than 20,000 products. WebRxSM features one of the largest on-line selections of vitamins, a Vision Center and a Comfort Living department (www.comfortliving.com) with a broad range of products including maternity and baby care, ergonomic chairs, water purifiers and an extensive line of allergy control products. HealthCentral.com (www.healthcentral.com) provides health-related information and commentary by Dr. Dean Edell, MD and other experts. RxList.com (www.rxlist.com) provides both patient-focused and professional-focused prescription drug information monographs.
Forward Looking Statements:
Except for historical information, the statements in this news release are forward-looking statements, involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. Potential risks and uncertainties include, but are not limited to, the possible delisting of the Company`s stock from the Nasdaq National Market, the Company`s limited operating history and need to generate revenues, the Company`s need to raise additional cash, the substantial competition in the e-health market, the Company`s ability to successfully implement its operational plan, including proposed cost-cutting measures, possible liability related to product or content on or accessed through the Company`s web sites, the need to build a brand name quickly, the effect of substantial and changing government regulation, possible systems interruptions, a failure to integrate acquisitions or manage resources, and a failure to retain key employees. Further information regarding these and other risks is included in HealthCentral.com`s Quarterly Reports on Form 10-Q for the quarters ended June 30, 2001 and March 31, 2001, Annual Report on Form 10-K for the year ended December 31, 2000 and other documents filed with the SEC.
###
For Information Contact:
Diane Jankiewicz
HealthCentral Investor Relations
Phone: 510-250-2658
dianej@healthcentral.com
Melanie Hilario
HealthCentral Public Relations
Phone: 510-250-3806
melanie.hilario@healthcentral.com
Back...
